Holen Sie sich die Stockscreener-App
10.61
2.02%
0.21
Handel nachbörslich:
10.73
0.12
+1.13%
Schlusskurs vom Vortag:
$10.40
Offen:
$10.24
24-Stunden-Volumen:
1.06M
Relative Volume:
0.91
Marktkapitalisierung:
$655.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-130.41M
KGV:
-4.7366
EPS:
-2.24
Netto-Cashflow:
$-67.76M
1W Leistung:
+43.77%
1M Leistung:
+120.58%
6M Leistung:
+140.59%
1J Leistung:
+115.65%
1-Tages-Spanne:
$10.08
$10.70
1-Wochen-Bereich:
$7.435
$10.70
52-Wochen-Spanne:
$3.5001
$12.40
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Firmenname
Monte Rosa Therapeutics Inc
Sektor
Branche
Telefon
617-949-2643
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie GLUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
10.61 | 620.06M | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-01-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Eingeleitet | UBS | Buy |
| 2022-08-15 | Eingeleitet | Jefferies | Buy |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-10-14 | Eingeleitet | SVB Leerink | Mkt Perform |
Alle ansehen
Monte Rosa Therapeutics Inc Aktie (GLUE) Neueste Nachrichten
Using data models to predict Monte Rosa Therapeutics Inc. stock movementEarnings Beat & High Accuracy Buy Signal Tips - newser.com
Why Monte Rosa Therapeutics Inc. stock is popular among millennialsDip Buying & AI Enhanced Trading Alerts - newser.com
Applying sector rotation models to Monte Rosa Therapeutics Inc.Profit Target & Step-by-Step Trade Execution Guides - newser.com
Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolution2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Using economic indicators to assess Monte Rosa Therapeutics Inc. potentialTreasury Yields & AI Powered Market Entry Strategies - newser.com
Custom watchlist performance reports with Monte Rosa Therapeutics Inc.Watch List & Daily Entry Point Trade Alerts - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Trading Up 7.9%Here's Why - MarketBeat
Monte Rosa Therapeutics Inc. stock momentum explainedWeekly Gains Summary & Verified Entry Point Signals - newser.com
What analysts say about Monte Rosa Therapeutics Inc stockValue Traps to Avoid & Outstanding Growth Strategies - earlytimes.in
Does Monte Rosa Therapeutics Inc. fit your quant trading modelJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Monte Rosa Therapeutics Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
Signal strength of Monte Rosa Therapeutics Inc. stock in tech scannersDollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Earns "Sell (D)" Rating from Weiss Ratings - MarketBeat
Will Monte Rosa Therapeutics Inc. see short term momentum2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Comparing Monte Rosa Therapeutics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
How high can Monte Rosa Therapeutics Inc. stock goShort Setup & Advanced Technical Analysis Signals - newser.com
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects - Insider Monkey
11 Best Fast Money Stocks to Buy Now - Insider Monkey
Is Monte Rosa Therapeutics Inc a good long term investmentGeopolitical Risk Analysis & Consistent Double Returns - earlytimes.in
Monte Rosa Therapeutics Inc Stock Analysis and ForecastLarge Cap Stability Picks & Fast Profit Trading Ideas - earlytimes.in
Full technical analysis of Monte Rosa Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - newser.com
Is Monte Rosa Therapeutics Inc. stock reversal real or fakeWatch List & Daily Chart Pattern Signals - newser.com
Monte Rosa Therapeutics Inc. stock trend forecastJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Pallas Capital Advisors LLC Makes New $59,000 Investment in Monte Rosa Therapeutics, Inc. $GLUE - Defense World
Monte Rosa Therapeutics presents new CDK2 degradation inducers - BioWorld MedTech
Monte Rosa Is Building The ‘Next RNAi’ Through AI-Powered Molecular Glue Discovery - insights.citeline.com
Will Monte Rosa Therapeutics Inc. stock go up soonJuly 2025 Fed Impact & Community Consensus Picks - newser.com
Sentiment analysis tools applied to Monte Rosa Therapeutics Inc.July 2025 Big Picture & Stepwise Entry and Exit Trade Signals - newser.com
Q3 EPS Forecast for Monte Rosa Therapeutics Cut by Analyst - MarketBeat
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):